111 related articles for article (PubMed ID: 2667627)
1. Monoclonal antibodies and their usefulness in epithelial ovarian cancer. A review.
Crowther ME; Britton KE; Granowska M; Shepherd JH
Br J Obstet Gynaecol; 1989 May; 96(5):516-21. PubMed ID: 2667627
[No Abstract] [Full Text] [Related]
2. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies].
Bar J; Sobańska E
Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
[No Abstract] [Full Text] [Related]
4. A radioimmunoassay for ovarian cancer.
Lewis JL
N Engl J Med; 1983 Oct; 309(15):919-21. PubMed ID: 6888485
[No Abstract] [Full Text] [Related]
5. The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma.
Bast RC; Knapp RC
Important Adv Oncol; 1987; ():39-53. PubMed ID: 3331386
[No Abstract] [Full Text] [Related]
6. A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.
Dhokia B; Canney PA; Pectasides D; Munro AJ; Moore M; Wilkinson PM; Self C; Epenetos AA
Br J Cancer; 1986 Dec; 54(6):891-5. PubMed ID: 3467785
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications.
Mainguené C; Aillet G; Kremer M; Chatal JF
J Nucl Med Allied Sci; 1986; 30(1):19-22. PubMed ID: 3528419
[No Abstract] [Full Text] [Related]
8. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
9. Potential usefulness of monoclonal antibodies in invasive ovarian adenocarcinoma.
Patsner B; Day TG; Rao CV
J Ky Med Assoc; 1986 Nov; 84(11):613-5. PubMed ID: 3466996
[No Abstract] [Full Text] [Related]
10. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
[No Abstract] [Full Text] [Related]
11. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
Bast RC; Klug TL; St John E; Jenison E; Niloff JM; Lazarus H; Berkowitz RS; Leavitt T; Griffiths CT; Parker L; Zurawski VR; Knapp RC
N Engl J Med; 1983 Oct; 309(15):883-7. PubMed ID: 6310399
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies and the biological approach to cancer.
Carter PW
J Biol Response Mod; 1985 Aug; 4(4):325-39. PubMed ID: 4031950
[No Abstract] [Full Text] [Related]
13. Immunodiagnosis of ovarian tumors.
Jacobs I; Bast RC
Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
[No Abstract] [Full Text] [Related]
14. [Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer. CA 125 as a tumor marker. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Kaesemann H; Caffier H; Hoffmann FJ; Crombach G; Würz H; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G
Klin Wochenschr; 1986 Sep; 64(17):781-5. PubMed ID: 3463828
[TBL] [Abstract][Full Text] [Related]
15. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor-associated antigen detected by the murine monoclonal antibody CF511 in human epithelial ovarian carcinoma.
Murae M; Ohkawa K; Kimura E
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1841-8. PubMed ID: 2687410
[TBL] [Abstract][Full Text] [Related]
17. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of ovarian tumor antigen NB/70K: monoclonal antibody assays for distinguishing ovarian cancer from other gynecologic disease.
Knauf S
Am J Obstet Gynecol; 1988 May; 158(5):1067-72. PubMed ID: 3369485
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of CA.125 as a co-adjuvant test in the diagnosis and follow-up of ovarian cancer].
Hernández Briz MJ; Díaz Redondo A; Mújica Menéndez I; Merino Ramírez J; Crespo Azanza E; Fernández Villoria E; Sánchez Martín JA
Rev Clin Esp; 1986 Oct; 179(5):240-2. PubMed ID: 3466260
[No Abstract] [Full Text] [Related]
20. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
